biomolecular condensates

Volastra bumps up seed round to $44M, inks Microsoft partnership

Volastra Therapeutics is taking aim at metastatic cancer by targeting chromosomal instability, a hallmark of solid tumors that’s linked to metastasis.

Amirah Al Idrus Apr 6, 2021 7:00am

Northern Biologics chief hops over to helm Faze Medicines

Jan 25, 2021 10:00am

Scientists wearing lab coats and masks in a lab

With $81M Faze launch, the condensates field gathers steam

Dec 10, 2020 7:00am